Analytical Data
-
基因名
MYOZ2
- Application
-
别名
MYOZ2；C4orf5；Myozenin-2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NPC6
-
表达区间
1-264aa
-
氨基酸序列
MLSHNTMMKQRKQQATAIMKEVHGNDVDGMDLGKKVSIPRDIMLEELSHL SNRGARLFKMRQRRSDKYTFENFQYQSRA QINHSIAMQNGKVDGSNLE GGSQQAPLTPPNTPDPRSPPNPDNIAPGYSGPLKEIPPEKFNTTAVPKYY QSPWEQAISNDPELLEALYPKLFKPEGKAELPDYRSFNRVATPFGGFEKA SRMVKFKVPDFELLLLTDPRFMSFVNPLSGRRSFNRTPKGWISENIPIVI TTEPTDDTTVPESEDLLEHHHHHH
-
分子量
31 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYOZ2, a member of the myozenin family, is primarily expressed in skeletal muscle and plays a crucial role in linking myofibrils and the sarcoplasmic reticulum, thus contributing to muscle contraction and maintenance. Recent studies have suggested that MYOZ2 may have significant implications in muscle development, repair, and overall muscle function. Abnormalities in MYOZ2 expression have been associated with various muscular disorders, making it a potential biomarker for muscle-related diseases. Researchers have increasingly focused on the recombinant production of MYOZ2 to analyze its structure-function relationships and to explore its role in cellular mechanisms involved in muscle physiology. By utilizing recombinant DNA technology, scientists can produce MYOZ2 in controlled laboratory settings, allowing for detailed functional assays, interaction studies, and potential therapeutic applications. Understanding the dynamics of MYOZ2 through recombinant protein studies could provide insights into muscle pathologies and contribute to the development of targeted therapies for muscle degenerative diseases, thereby enhancing recovery strategies and muscle health in various clinical settings.
